Firefly Neuroscience (AIFF)
NASDAQ:AIFF
Want to see AIFF full AI Analyst Report?
AIFF Stock Chart & Stats
$1.05
-$0.10(-4.05%)
At close: 4:00 PM EST
$1.05
-$0.10(-4.05%)
Day’s Range― - ―
52-Week Range$0.62 - $3.63
Previous CloseN/A
Volume11.65K
Average Volume (3M)316.76K
Market Cap
$20.40M
Enterprise Value$19.30M
Total Cash (Recent Filing)$3.13M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.34
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.68
Shares Outstanding15,571,780
10 Day Avg. Volume358,037
30 Day Avg. Volume316,761
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)1.51
Price to Sales (P/S)10.11
P/FCF Ratio-1.39
Enterprise Value/Market Cap0.95
Enterprise Value/Revenue12.18
Enterprise Value/Gross Profit23.45
Enterprise Value/Ebitda-2.21
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth & Gross MarginSustained TTM revenue growth (~+38.7%) alongside ~52% gross margin indicates product-market fit and scalable unit economics. Over the next 2–6 months, this supports margin leverage as revenue rises and gives a clearer path to operating leverage if fixed costs are controlled and growth continues.
Debt-Free Balance SheetNo debt and positive equity reduce solvency risk and lower fixed financial obligations, providing strategic flexibility. This durable strength makes future financing less pressured by creditor covenants and gives management room to prioritize product and R&D investment rather than servicing debt.
Completed $8M Private PlacementAn $8M equity infusion materially extends near-term runway and supports continued product development and commercialization efforts. Structurally, this funding reduces immediate liquidity pressure and allows management to execute medium-term operational milestones without immediate revenue breakeven.
Bears Say
Extremely Weak ProfitabilityVery large negative net margins demonstrate that current revenue is far from covering operating costs. Persisting such losses makes sustained investment dependent on external capital, limits reinvestment from operations, and raises execution risk before reaching durable profitability.
Material Cash Burn / Negative FCFFree cash flow is deeply negative and closely tracks net losses, signaling cash burn is real rather than primarily non-cash charges. Over months this reduces runway absent further financing, constrains discretionary spend on growth, and increases the likelihood of repeated capital raises.
Financing Dependence & Dilution RiskHistory of negative equity and reliance on private placements indicate structural funding dependence. While financings provide runway, they also dilute shareholders and can lead to recurring capital raises if operating cash flow doesn’t improve, pressuring long-term shareholder returns and strategic choices.
Firefly Neuroscience News
AIFF FAQ
What was Firefly Neuroscience’s price range in the past 12 months?
Firefly Neuroscience lowest stock price was $0.62 and its highest was $3.63 in the past 12 months.
What is Firefly Neuroscience’s market cap?
Firefly Neuroscience’s market cap is $20.40M.
When is Firefly Neuroscience’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Firefly Neuroscience’s earnings last quarter?
Firefly Neuroscience released its earnings results on May 14, 2024. The company reported -$0.335 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.335.
Is Firefly Neuroscience overvalued?
According to Wall Street analysts Firefly Neuroscience’s price is currently Overvalued.
Does Firefly Neuroscience pay dividends?
Firefly Neuroscience does not currently pay dividends.
What is Firefly Neuroscience’s EPS estimate?
Firefly Neuroscience’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Firefly Neuroscience have?
Firefly Neuroscience has 15,571,780 shares outstanding.
What happened to Firefly Neuroscience’s price movement after its last earnings report?
Firefly Neuroscience reported an EPS of -$0.335 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.455%.
Which hedge fund is a major shareholder of Firefly Neuroscience?
Currently, no hedge funds are holding shares in AIFF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Firefly Neuroscience
Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Firefly Neuroscience, Inc. caters to both pharmaceutical companies and medical practitioners.
Technical Analysis
Ownership Overview
11.85% Insiders
1.30% Mutual Funds
0.47% Other Institutional Investors
85.46% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---